A Discrete-Event, Simulated Social Agent-Based Network Transmission (DESSABNeT) model for communicable diseases: Method and validation using SARS-CoV-2 data in three large Australian cities.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2021
2021
Historique:
received:
25
11
2020
accepted:
01
05
2021
entrez:
21
5
2021
pubmed:
22
5
2021
medline:
3
6
2021
Statut:
epublish
Résumé
During pandemics Agent Based Models (ABMs) can model complex, fine-grained behavioural interactions occurring in social networks, that contribute to disease transmission by novel viruses such as SARS-CoV-2. We present a new agent-based model (ABM) called the Discrete-Event, Simulated Social Agent based Network Transmission model (DESSABNeT) and demonstrate its ability to model the spread of COVID-19 in large cities like Sydney, Melbourne and Gold Coast. Our aim was to validate the model with its disease dynamics and underlying social network. DESSABNeT relies on disease transmission within simulated social networks. It employs an epidemiological SEIRD+M (Susceptible, exposed, infected, recovered, died and managed) structure. One hundred simulations were run for each city, with simulated social restrictions closely modelling real restrictions imposed in each location. The mean predicted daily incidence of COVID-19 cases were compared to real case incidence data for each city. Reff and health service utilisation outputs were compared to the literature, or for the Gold Coast with daily incidence of hospitalisation. DESSABNeT modelled multiple physical distancing restrictions and predicted epidemiological outcomes of Sydney, Melbourne and the Gold Coast, validating this model for future simulation work. DESSABNeT is a valid platform to model the spread of COVID-19 in large cities in Australia and potentially internationally. The platform is suitable to model different combinations of social restrictions, or to model contact tracing, predict, and plan for, the impact on hospital and ICU admissions, and deaths; and also the rollout of COVID-19 vaccines and optimal social restrictions during vaccination.
Identifiants
pubmed: 34019561
doi: 10.1371/journal.pone.0251737
pii: PONE-D-20-37064
pmc: PMC8139469
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Validation Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0251737Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
N Engl J Med. 2020 Mar 26;382(13):1199-1207
pubmed: 31995857
PLoS Med. 2020 Sep 22;17(9):e1003346
pubmed: 32960881
Lancet Public Health. 2021 Mar;6(3):e175-e183
pubmed: 33484644
PLoS Comput Biol. 2010 Jan 29;6(1):e1000656
pubmed: 20126529
Lancet Child Adolesc Health. 2020 Nov;4(11):807-816
pubmed: 32758454
Nat Commun. 2020 Nov 11;11(1):5710
pubmed: 33177507
Nat Med. 2020 May;26(5):672-675
pubmed: 32296168
Lancet. 2020 Mar 28;395(10229):1054-1062
pubmed: 32171076
Nat Med. 2020 Sep;26(9):1398-1404
pubmed: 32647358
Ann Intern Med. 2020 May 5;172(9):577-582
pubmed: 32150748
Elife. 2020 Aug 13;9:
pubmed: 32788039
J Clin Med. 2020 Feb 17;9(2):
pubmed: 32079150
Lancet Infect Dis. 2020 May;20(5):553-558
pubmed: 32171059